For example, the FABP4|high group had a higher metastasis rate than the KLK12|high group (TCGA-CRC: 24 vs. 12%, p = 0.001; GSE29621: 57 vs. 25%, p = 0.173; and GSE39084: 31 vs. 31%, p = 1.000) (Figures 8H–J), and more metastatic cases were in the FABP4|high group than in the GBP5|high group (GSE29621: 44 vs. 23%, p = 0.199; and GSE39084: 44 vs. 27%, p = 0.278) (Figures 8K,L). The gene discussed is FABP4; the disease is colorectal carcinoma.